Biotricity, B-Secur Augment Next-Generation Cardiac Monitoring Platform

Biotricity Inc. and B-Secur are stepping up their game in the consumer wearables market with an enhancement to their joint cardiac monitoring platform.

Launched earlier this year for ambulatory cardiac monitoring, the device-neutral platform will now support ECG data from consumer wearables. This advancement enables the seamless integration and review of user data collected from smartwatches, smart rings, fitness trackers, and other mobile health products within Biotricity’s cloud-based medical workflow. 

Executives from both companies said the move solidifies Biotricity and B-Secur’s leadership in digital cardiovascular innovation, positioning the organizations at the forefront of the rapidly expanding heart health market.

“Biotricity’s mission has been to make high-quality cardiac care accessible to everyone,” Biotricity Founder/CEO Dr. Waqaas Al-Siddiq said. “Through our strategic collaboration with B-Secur, we’re introducing clinical-grade heart monitoring to consumer wearables, providing patients and their healthcare providers with the tools they need to understand and manage heart health like never before.”

Leveraging B-Secur’s U.S. Food and Drug Administration-cleared HeartKey ECG algorithms and advanced analytics, the platform delivers medical-grade accuracy for healthcare professionals. Its device-agnostic design and cloud-enabled infrastructure allow developers and OEMs to seamlessly integrate data from smart devices into regulated care pathways, efficiently bridging the gap between consumer devices and clinical care.

“This advancement addresses the growing global demand for preventive cardiovascular solutions in younger and aging populations,” B-Secur Medical Vice President Tyeler Dean stated. “It enables scalable, user-friendly health tech while maintaining the same level of clinical-grade accuracy trusted by healthcare professionals and increasingly expected by consumers.”

Cardiovascular disease, responsible for one in three deaths worldwide, is projected to triple global costs to $1.8 trillion by 2050, according to industry statistics. This increase underscores the urgent need for scalable, preventative technologies that enable early diagnoses and intervention, ultimately improving long-term outcomes while reducing healthcare costs.

B-Secur is an advanced biosensing technology company developing on-device and cloud applications, driving preventative and proactive fitness and health management. B-Secur’s signal processing provides medical-grade ECG data for faster, more confident diagnosis, treatment, and management. B-Secur is ISO 13485:2016 certified. 

Biotricity strives to bridge the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity’s standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops remote health monitoring solutions for the medical and consumer markets.